Randomized, Controlled Trial to Evaluate the Effect of Dapagliflozin on Left Ventricular Diastolic Function in Patients With Type 2 Diabetes Mellitus: The IDDIA Trial

Chi Young Shim; Jiwon Seo; Iksung Cho; Chan Joo Lee; In Jeong Cho; Purevjargal Lhagvasuren; Seok Min Kang; Jong Won Ha; Gyoonhee Han; Yangsoo Jang; Geu Ru Hong

doi:10.1161/CIRCULATIONAHA.120.051992

Randomized, Controlled Trial to Evaluate the Effect of Dapagliflozin on Left Ventricular Diastolic Function in Patients With Type 2 Diabetes Mellitus: The IDDIA Trial

Chi Young Shim, Jiwon Seo, Iksung Cho, Chan Joo Lee, In Jeong Cho, Purevjargal Lhagvasuren, Seok Min Kang, Jong Won Ha, Gyoonhee Han, Yangsoo Jang, Geu Ru Hong

Department of Internal Medicine

Research output: Contribution to journal › Article › peer-review

56 Scopus citations

Original language	English
Pages (from-to)	510-512
Number of pages	3
Journal	Circulation
Volume	143
Issue number	5
DOIs	https://doi.org/10.1161/CIRCULATIONAHA.120.051992
State	Published - 2 Feb 2021

Bibliographical note

Funding Information:
The IDDIA trial was an investigator-initiated trial funded by AstraZeneca. All analyses were conducted independently, and all authors had full access to the data. The authors are fully responsible for the study design; the collection, analysis and interpretation of the data; and the writing of the manuscript. The sponsor played no role in the decision to submit the manuscript for publication. This research was also supported by a grant of the Korea Health Technology Research and Development Project through the Korea Health Industry Development Institute, funded by the Ministry of Health and Welfare, Republic of Korea (grant number: HI20C1566).

Keywords

diabetes mellitus
diastole
echocardiography, stress
function
sodium-glucose transporter 2 inhibitors

Access to Document

10.1161/CIRCULATIONAHA.120.051992

Cite this

Shim, C. Y., Seo, J., Cho, I., Lee, C. J., Cho, I. J., Lhagvasuren, P., Kang, S. M., Ha, J. W., Han, G., Jang, Y., & Hong, G. R. (2021). Randomized, Controlled Trial to Evaluate the Effect of Dapagliflozin on Left Ventricular Diastolic Function in Patients With Type 2 Diabetes Mellitus: The IDDIA Trial. Circulation, 143(5), 510-512. https://doi.org/10.1161/CIRCULATIONAHA.120.051992

@article{6888e4001b1b4b90b1f15b7f9a5e233f,

title = "Randomized, Controlled Trial to Evaluate the Effect of Dapagliflozin on Left Ventricular Diastolic Function in Patients With Type 2 Diabetes Mellitus: The IDDIA Trial",

keywords = "diabetes mellitus, diastole, echocardiography, stress, function, sodium-glucose transporter 2 inhibitors",

author = "Shim, {Chi Young} and Jiwon Seo and Iksung Cho and Lee, {Chan Joo} and Cho, {In Jeong} and Purevjargal Lhagvasuren and Kang, {Seok Min} and Ha, {Jong Won} and Gyoonhee Han and Yangsoo Jang and Hong, {Geu Ru}",

note = "Funding Information: The IDDIA trial was an investigator-initiated trial funded by AstraZeneca. All analyses were conducted independently, and all authors had full access to the data. The authors are fully responsible for the study design; the collection, analysis and interpretation of the data; and the writing of the manuscript. The sponsor played no role in the decision to submit the manuscript for publication. This research was also supported by a grant of the Korea Health Technology Research and Development Project through the Korea Health Industry Development Institute, funded by the Ministry of Health and Welfare, Republic of Korea (grant number: HI20C1566).",

year = "2021",

month = feb,

day = "2",

doi = "10.1161/CIRCULATIONAHA.120.051992",

language = "English",

volume = "143",

pages = "510--512",

journal = "Circulation",

issn = "0009-7322",

publisher = "Lippincott Williams and Wilkins Ltd.",

number = "5",

}

Shim, CY, Seo, J, Cho, I, Lee, CJ, Cho, IJ, Lhagvasuren, P, Kang, SM, Ha, JW, Han, G, Jang, Y & Hong, GR 2021, 'Randomized, Controlled Trial to Evaluate the Effect of Dapagliflozin on Left Ventricular Diastolic Function in Patients With Type 2 Diabetes Mellitus: The IDDIA Trial', Circulation, vol. 143, no. 5, pp. 510-512. https://doi.org/10.1161/CIRCULATIONAHA.120.051992

TY - JOUR

T1 - Randomized, Controlled Trial to Evaluate the Effect of Dapagliflozin on Left Ventricular Diastolic Function in Patients With Type 2 Diabetes Mellitus

T2 - The IDDIA Trial

AU - Shim, Chi Young

AU - Seo, Jiwon

AU - Cho, Iksung

AU - Lee, Chan Joo

AU - Cho, In Jeong

AU - Lhagvasuren, Purevjargal

AU - Kang, Seok Min

AU - Ha, Jong Won

AU - Han, Gyoonhee

AU - Jang, Yangsoo

AU - Hong, Geu Ru

N1 - Funding Information: The IDDIA trial was an investigator-initiated trial funded by AstraZeneca. All analyses were conducted independently, and all authors had full access to the data. The authors are fully responsible for the study design; the collection, analysis and interpretation of the data; and the writing of the manuscript. The sponsor played no role in the decision to submit the manuscript for publication. This research was also supported by a grant of the Korea Health Technology Research and Development Project through the Korea Health Industry Development Institute, funded by the Ministry of Health and Welfare, Republic of Korea (grant number: HI20C1566).

PY - 2021/2/2

Y1 - 2021/2/2

KW - diabetes mellitus

KW - diastole

KW - echocardiography, stress

KW - function

KW - sodium-glucose transporter 2 inhibitors

UR - http://www.scopus.com/inward/record.url?scp=85097938907&partnerID=8YFLogxK

U2 - 10.1161/CIRCULATIONAHA.120.051992

DO - 10.1161/CIRCULATIONAHA.120.051992

M3 - Article

C2 - 33186508

AN - SCOPUS:85097938907

SN - 0009-7322

VL - 143

SP - 510

EP - 512

JO - Circulation

JF - Circulation

IS - 5

ER -